Articles

The integration of the binders into a routine lateral flow test will support the clinical and commercial development of rapid diagnostics for Alzheimer’s disease through nasal sampling.

Aptamer Group and Neuro-Bio Collaborate to Develop Alzheimer’s Disease Diagnostic Test

Mendus and NorthX Biologics will work to develop and commercialize Mendus’ lead asset, vididencel, an allogeneic dendritic cell vaccine.

Mendus and NorthXBiologics Enter Cell Therapy Manufacturing Alliance

Charles River’s off-the-shelf lentiviral vector packaging plasmids are intended for use with cell and gene therapies.


Charles River Laboratories Launches LVV Packaging Plasmids

The investment, which is taking place in Hillerød, Denmark, will aim to create more production capacity and increase the company’s ability to meet future market demands and to continue development on its future clinical late-phase product portfolio.

Novo Nordisk to Expand Manufacturing Facilities in Hillerød, Denmark

The deal, valued at more than $2 billion dollars, will see Quell Therapeutics develop various T-regulatory cell therapies for AstraZeneca.

AstraZeneca and Quell Therapeutics Strike Cell Therapy Development Deal

The new excipients manufacturing facility is expected to be completed in 2025.

Croda Pharma Breaks Ground on Excipients Manufacturing Facility

The merger agreement states that Novartis will acquire all the shares of Chinook through a subsidiary for a price of $40 per share in cash at closing.

Chinook Therapeutics Acquired by Novartis AG

Chris Spivey is director of Industry Relations and Strategic Partnership, MJH Life Sciences.

World leaders have set ambitious goals to respond more swiftly to the next pandemic, including the US goal to design, test, and review a new vaccine just 100 days after a pandemic declaration. 

mRNA Global Alliance Tests the Waters at BIO

This will allow industry leaders to make and sell the product, in addition to providing more choice to pharma and biotech companies.

New Velocity Vials Technology Platform to Expand Industry Partnerships

The collaboration between Samsung Biologics and Pfizer will focus on long-term biosimilars manufacturing.

News